Tus kws kho mob
P10-18 Blue Cross Will Cease Mailing Certain Provider Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2018
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2621 - 2630 ntawm 4205
Tus kws kho mob
P19R1-17 New Remittance Code: OA-45 for Purchased/Referred (PRC)-Eligible Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 24, 2017
Tus kws kho mob
P8-18 Changes to PA for Hip Arthroplasty, Hip Resurfacing and Knee Arthroplasty for Commercial and Government Programs Lines of Business
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 08, 2018
Tus kws kho mob
P78-17 Cotiviti to Perform Inpatient Claims Reviews
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 12, 2017
Tus kws kho mob
P54-17 Clarification to Commercial Prior Authorization Requirements for Early Intensive Behavioral Intervention (EIBI)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 10, 2017
Tus kws kho mob
P23-18 Clinical Reviews for Court-Ordered Substance Use Disorder Treatment
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P2R1-18 Updated: New Medical Drug Prior Authorization Requirements for Voretigene Neparvovec (Luxturna)
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 02, 2018
Tus kws kho mob
P3-18 New Drug-Related PA Criteria: Inhaled Antibiotics Duplicate Therapy
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 24, 2018
Tus kws kho mob
Medical Management Referral Form
Tus kws kho mob
P43-17 New Drug-Related Prior Authorization Criteria for Symbicort
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 07, 2017